PROF

Profound Medical

Stock NASDAQ – Stock Market Prices, News & Analysis

Profound Medical Corp develops and commercializes personalized therapy systems for the ablation of soft tissues using focused ultrasound.

$ 5.41
3.44 %

Profound Medical

$ 5.41
3.44 %
PROF

Profound Medical Corp develops and commercializes personalized therapy systems for the ablation of soft tissues using focused ultrasound.

Price history of Profound Medical
Price history of Profound Medical

Performance & Momentum

6 Months 36.62 %
1 Year 20.67 %
3 Years 47.88 %
5 Years 76.67 %
Momentum
79

Strategic Analysis

Profound Medical • 2026

Profound Medical Corp positions itself as an innovative player in the healthcare sector, specializing in focused ultrasound tissue ablation systems, addressing the growing need for minimally invasive and personalized therapies. Its model is based on technological development and the commercialization of advanced medical equipment aimed at demanding global markets.

Strengths
  • Differentiated technology offering a non-invasive alternative to conventional treatments
  • Strong focus on the customization of care, in line with current medical trends
  • Growth potential linked to gradual adoption across multiple clinical indications
Weaknesses
  • Financial history marked by negative long-term stock performance
  • Relatively weak stock momentum indicating limited adoption or market uncertainties
Momentum

After a strong recent improvement, the momentum remains moderate, suggesting a temporary increase in interest possibly linked to commercial or clinical advancements. Investors should monitor sales trends and the expansion of indications to confirm sustainable momentum.

Analysis performed 2 days ago

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone